Rank | Gene Set | Z-score |
---|---|---|
1 | regulation of sister chromatid cohesion (GO:0007063) | 9.49297655 |
2 | negative regulation of catenin import into nucleus (GO:0035414) | 8.84181072 |
3 | production of molecular mediator involved in inflammatory response (GO:0002532) | 8.45886084 |
4 | specification of organ identity (GO:0010092) | 7.98017924 |
5 | regulation of catenin import into nucleus (GO:0035412) | 7.72763785 |
6 | positive regulation of catenin import into nucleus (GO:0035413) | 7.66461841 |
7 | response to hydroperoxide (GO:0033194) | 7.50193648 |
8 | dorsal/ventral axis specification (GO:0009950) | 7.13788596 |
9 | receptor catabolic process (GO:0032801) | 6.97836802 |
10 | inflammatory response to antigenic stimulus (GO:0002437) | 6.77919377 |
11 | response to methylmercury (GO:0051597) | 6.37037860 |
12 | granulocyte differentiation (GO:0030851) | 5.89272477 |
13 | photoreceptor cell differentiation (GO:0046530) | 5.87303284 |
14 | eye photoreceptor cell differentiation (GO:0001754) | 5.87303284 |
15 | positive regulation of epithelial to mesenchymal transition (GO:0010718) | 5.81634519 |
16 | cranial suture morphogenesis (GO:0060363) | 5.59449883 |
17 | protoporphyrinogen IX biosynthetic process (GO:0006782) | 5.56464421 |
18 | tooth mineralization (GO:0034505) | 5.51754694 |
19 | arachidonic acid secretion (GO:0050482) | 5.27110529 |
20 | icosanoid secretion (GO:0032309) | 5.27110529 |
21 | response to insecticide (GO:0017085) | 5.24010384 |
22 | response to fungus (GO:0009620) | 5.13792799 |
23 | positive regulation of dendritic spine morphogenesis (GO:0061003) | 4.98158743 |
24 | positive regulation of vesicle fusion (GO:0031340) | 4.90179182 |
25 | protoporphyrinogen IX metabolic process (GO:0046501) | 4.87564348 |
26 | hepatocyte apoptotic process (GO:0097284) | 4.84333356 |
27 | lipoxygenase pathway (GO:0019372) | 4.69276239 |
28 | innate immune response in mucosa (GO:0002227) | 4.61244269 |
29 | low-density lipoprotein particle clearance (GO:0034383) | 4.54552748 |
30 | regulation of transcription from RNA polymerase II promoter involved in heart development (GO:190121 | 4.53997448 |
31 | viral transcription (GO:0019083) | 4.53020732 |
32 | bone trabecula formation (GO:0060346) | 4.50381254 |
33 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.43254685 |
34 | icosanoid transport (GO:0071715) | 4.42541282 |
35 | fatty acid derivative transport (GO:1901571) | 4.42541282 |
36 | translational termination (GO:0006415) | 4.36019587 |
37 | positive regulation of male gonad development (GO:2000020) | 4.25421148 |
38 | response to lead ion (GO:0010288) | 4.23145336 |
39 | negative regulation of bone mineralization (GO:0030502) | 4.18577109 |
40 | regulation of male gonad development (GO:2000018) | 4.18273536 |
41 | ribosomal small subunit biogenesis (GO:0042274) | 4.17636707 |
42 | layer formation in cerebral cortex (GO:0021819) | 4.13939248 |
43 | maturation of SSU-rRNA (GO:0030490) | 4.11213966 |
44 | otic vesicle formation (GO:0030916) | 4.06325019 |
45 | nuclear pore organization (GO:0006999) | 4.05123555 |
46 | nuclear pore complex assembly (GO:0051292) | 4.03458830 |
47 | regulation of macrophage cytokine production (GO:0010935) | 3.99754938 |
48 | translational elongation (GO:0006414) | 3.99738376 |
49 | regulation of translational fidelity (GO:0006450) | 3.90964866 |
50 | negative regulation of interleukin-8 production (GO:0032717) | 3.89438219 |
51 | mucosal immune response (GO:0002385) | 3.88879632 |
52 | L-serine transport (GO:0015825) | 3.84951233 |
53 | negative regulation of biomineral tissue development (GO:0070168) | 3.84740850 |
54 | positive regulation of guanylate cyclase activity (GO:0031284) | 3.80594027 |
55 | dendritic spine organization (GO:0097061) | 3.75898598 |
56 | retinal cone cell development (GO:0046549) | 3.75806399 |
57 | positive regulation of hair cycle (GO:0042635) | 3.74694610 |
58 | positive regulation of hair follicle development (GO:0051798) | 3.74694610 |
59 | ribosomal small subunit assembly (GO:0000028) | 3.74404353 |
60 | cellular protein complex localization (GO:0034629) | 3.74316540 |
61 | regulation of rhodopsin mediated signaling pathway (GO:0022400) | 3.73331841 |
62 | negative regulation of epidermal cell differentiation (GO:0045605) | 3.70115985 |
63 | SRP-dependent cotranslational protein targeting to membrane (GO:0006614) | 3.67263200 |
64 | cotranslational protein targeting to membrane (GO:0006613) | 3.66562920 |
65 | cellular response to antibiotic (GO:0071236) | 3.65045450 |
66 | regulation of branching involved in prostate gland morphogenesis (GO:0060687) | 3.59977712 |
67 | positive regulation of stem cell differentiation (GO:2000738) | 3.58987961 |
68 | protein targeting to ER (GO:0045047) | 3.53805884 |
69 | icosanoid biosynthetic process (GO:0046456) | 3.53638471 |
70 | fatty acid derivative biosynthetic process (GO:1901570) | 3.53638471 |
71 | epithelial to mesenchymal transition involved in endocardial cushion formation (GO:0003198) | 3.51522322 |
72 | response to phenylpropanoid (GO:0080184) | 3.48658172 |
73 | establishment of protein localization to endoplasmic reticulum (GO:0072599) | 3.47921709 |
74 | viral life cycle (GO:0019058) | 3.46718515 |
75 | negative regulation of T cell differentiation in thymus (GO:0033085) | 3.44992351 |
76 | leukotriene biosynthetic process (GO:0019370) | 3.44863320 |
77 | respiratory tube development (GO:0030323) | 3.44177031 |
78 | antibacterial humoral response (GO:0019731) | 3.43946354 |
79 | organ or tissue specific immune response (GO:0002251) | 3.42809121 |
80 | neutrophil activation involved in immune response (GO:0002283) | 3.42070428 |
81 | rhodopsin mediated signaling pathway (GO:0016056) | 3.41360125 |
82 | biotin metabolic process (GO:0006768) | 3.40587551 |
83 | pattern specification involved in kidney development (GO:0061004) | 3.39923370 |
84 | positive regulation of macrophage cytokine production (GO:0060907) | 3.39510233 |
85 | endocardial cushion morphogenesis (GO:0003203) | 3.38977179 |
86 | mesenchymal cell differentiation involved in renal system development (GO:2001012) | 3.38875781 |
87 | mesenchymal cell differentiation involved in kidney development (GO:0072161) | 3.38875781 |
88 | regulation of T cell cytokine production (GO:0002724) | 3.37153734 |
89 | cellular protein complex disassembly (GO:0043624) | 3.36885417 |
90 | collecting duct development (GO:0072044) | 3.35884441 |
91 | regulation of guanylate cyclase activity (GO:0031282) | 3.34253805 |
92 | regulation of Rap GTPase activity (GO:0032317) | 3.33883253 |
93 | regulation of cell proliferation involved in kidney development (GO:1901722) | 3.31632465 |
94 | protein localization to endoplasmic reticulum (GO:0070972) | 3.30036801 |
95 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184) | 3.28304046 |
96 | craniofacial suture morphogenesis (GO:0097094) | 3.26404417 |
97 | fatty acid transmembrane transport (GO:1902001) | 3.26027075 |
98 | serine transport (GO:0032329) | 3.25831870 |
99 | pore complex assembly (GO:0046931) | 3.25624598 |
100 | natural killer cell mediated immunity (GO:0002228) | 3.25335775 |
101 | natural killer cell mediated cytotoxicity (GO:0042267) | 3.25335775 |
102 | regulation of interleukin-8 secretion (GO:2000482) | 3.22904173 |
103 | ribosomal large subunit biogenesis (GO:0042273) | 3.21969808 |
104 | translational initiation (GO:0006413) | 3.21916321 |
105 | mesenchymal to epithelial transition involved in metanephros morphogenesis (GO:0003337) | 3.20175646 |
106 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 3.19548380 |
107 | Wnt signaling pathway, planar cell polarity pathway (GO:0060071) | 3.16837686 |
108 | positive regulation of sodium ion transmembrane transporter activity (GO:2000651) | 3.16290802 |
109 | cGMP-mediated signaling (GO:0019934) | 3.15348213 |
110 | regulation of mesenchymal cell apoptotic process (GO:2001053) | 3.10381099 |
111 | dendritic cell chemotaxis (GO:0002407) | 3.09720289 |
112 | negative regulation of metanephros development (GO:0072217) | 3.08988976 |
113 | hemidesmosome assembly (GO:0031581) | 3.08908796 |
114 | parturition (GO:0007567) | 3.07981595 |
115 | cell surface receptor signaling pathway involved in heart development (GO:0061311) | 3.05031310 |
116 | leukotriene metabolic process (GO:0006691) | 3.04392854 |
117 | photoreceptor cell development (GO:0042461) | 3.04016136 |
118 | positive regulation of monocyte chemotaxis (GO:0090026) | 3.03997162 |
119 | antimicrobial humoral response (GO:0019730) | 3.01974942 |
120 | nephron tubule formation (GO:0072079) | 3.01537607 |
121 | maintenance of gastrointestinal epithelium (GO:0030277) | 3.01125347 |
122 | mRNA stabilization (GO:0048255) | 3.00806139 |
123 | RNA stabilization (GO:0043489) | 3.00806139 |
124 | eye photoreceptor cell development (GO:0042462) | 2.99483844 |
125 | regulation of establishment of planar polarity (GO:0090175) | 2.98406912 |
126 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 2.94529233 |
127 | protein complex disassembly (GO:0043241) | 2.94030141 |
128 | microtubule severing (GO:0051013) | 2.93115294 |
129 | negative regulation of epidermis development (GO:0045683) | 2.91420244 |
130 | activation of MAPKKK activity (GO:0000185) | 2.90750974 |
131 | protein retention in ER lumen (GO:0006621) | 2.90278803 |
132 | wound healing, spreading of epidermal cells (GO:0035313) | 2.89730656 |
133 | myeloid dendritic cell differentiation (GO:0043011) | 2.89617674 |
134 | phagocytosis, recognition (GO:0006910) | 2.89236936 |
135 | macromolecular complex disassembly (GO:0032984) | 2.89224003 |
136 | response to lipoprotein particle (GO:0055094) | 2.89006070 |
137 | establishment of epithelial cell polarity (GO:0090162) | 2.88824377 |
138 | glomerular visceral epithelial cell development (GO:0072015) | 2.88681786 |
139 | skin morphogenesis (GO:0043589) | 2.88230691 |
140 | embryonic skeletal joint morphogenesis (GO:0060272) | 2.87104334 |
141 | regulation of myeloid cell apoptotic process (GO:0033032) | 2.85303514 |
142 | regulation of epithelial to mesenchymal transition (GO:0010717) | 2.85059435 |
143 | hepatocyte differentiation (GO:0070365) | 2.85024164 |
144 | negative regulation of cytokine production involved in immune response (GO:0002719) | 2.84957593 |
145 | arachidonic acid metabolic process (GO:0019369) | 2.84820455 |
146 | protein complex localization (GO:0031503) | 2.84451994 |
147 | positive regulation of extracellular matrix organization (GO:1903055) | 2.84167587 |
148 | termination of signal transduction (GO:0023021) | 2.83338563 |
149 | epithelial structure maintenance (GO:0010669) | 2.80729845 |
150 | detection of light stimulus involved in sensory perception (GO:0050962) | 2.79823429 |
151 | detection of light stimulus involved in visual perception (GO:0050908) | 2.79823429 |
152 | mast cell activation (GO:0045576) | 2.78320760 |
153 | male sex determination (GO:0030238) | 2.78274533 |
154 | formation of translation preinitiation complex (GO:0001731) | 2.77827447 |
155 | eosinophil chemotaxis (GO:0048245) | 2.77032128 |
156 | cellular component maintenance (GO:0043954) | 2.76961744 |
157 | ribonucleoprotein complex biogenesis (GO:0022613) | 2.75938663 |
158 | establishment of mitochondrion localization, microtubule-mediated (GO:0034643) | 2.75878159 |
159 | mitochondrion transport along microtubule (GO:0047497) | 2.75878159 |
160 | inositol phosphate dephosphorylation (GO:0046855) | 2.75054907 |
161 | phosphorylated carbohydrate dephosphorylation (GO:0046838) | 2.75054907 |
162 | positive regulation of epidermis development (GO:0045684) | 2.74809637 |
163 | regulation of chromosome segregation (GO:0051983) | 2.74454413 |
164 | regulation of hair follicle development (GO:0051797) | 2.74012131 |
165 | cyclooxygenase pathway (GO:0019371) | 2.72169801 |
166 | regulation of cell proliferation involved in heart morphogenesis (GO:2000136) | 2.69879070 |
167 | positive regulation of T cell cytokine production (GO:0002726) | 2.69408302 |
168 | response to progesterone (GO:0032570) | 2.69137296 |
169 | mast cell activation involved in immune response (GO:0002279) | 2.65294753 |
170 | mast cell degranulation (GO:0043303) | 2.65294753 |
171 | myeloid dendritic cell activation (GO:0001773) | 2.64908671 |
172 | cellular response to vitamin D (GO:0071305) | 2.64650965 |
173 | cellular response to toxic substance (GO:0097237) | 2.61594198 |
174 | long-chain fatty acid transport (GO:0015909) | 2.60317372 |
175 | long term synaptic depression (GO:0060292) | 2.58747384 |
176 | phototransduction (GO:0007602) | 2.58328368 |
177 | immunoglobulin mediated immune response (GO:0016064) | 2.56523337 |
178 | antigen processing and presentation via MHC class Ib (GO:0002475) | 2.56415768 |
179 | termination of G-protein coupled receptor signaling pathway (GO:0038032) | 2.55670716 |
180 | regulation of syncytium formation by plasma membrane fusion (GO:0060142) | 2.52697969 |
181 | heart valve formation (GO:0003188) | 2.50931523 |
182 | positive regulation of syncytium formation by plasma membrane fusion (GO:0060143) | 2.50902131 |
183 | regulation of cytokine production involved in immune response (GO:0002718) | 2.48730465 |
184 | phospholipid scrambling (GO:0017121) | 2.48723193 |
185 | leukocyte degranulation (GO:0043299) | 2.48000138 |
186 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 2.47194967 |
187 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 2.46297273 |
188 | inositol phosphate catabolic process (GO:0071545) | 2.45703418 |
189 | * sensory perception of taste (GO:0050909) | 2.45401972 |
190 | phototransduction, visible light (GO:0007603) | 2.44059552 |
191 | positive regulation of bone remodeling (GO:0046852) | 2.43052497 |
192 | positive regulation of bone resorption (GO:0045780) | 2.43052497 |
193 | prostanoid biosynthetic process (GO:0046457) | 2.42962104 |
194 | prostaglandin biosynthetic process (GO:0001516) | 2.42962104 |
195 | positive regulation of type 2 immune response (GO:0002830) | 2.42512067 |
196 | Rap protein signal transduction (GO:0032486) | 2.41597939 |
197 | regulation of water loss via skin (GO:0033561) | 2.41595587 |
198 | * detection of light stimulus (GO:0009583) | 2.41141857 |
199 | secondary heart field specification (GO:0003139) | 12.2396695 |
200 | heart field specification (GO:0003128) | 12.2396695 |
Rank | Gene Set | Z-score |
---|---|---|
1 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 8.51279300 |
2 | E2F7_22180533_ChIP-Seq_HELA_Human | 7.78353418 |
3 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 6.33304911 |
4 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 5.07470610 |
5 | GATA1_22025678_ChIP-Seq_K562_Human | 4.59727369 |
6 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 4.25504671 |
7 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 3.75134567 |
8 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 3.46344617 |
9 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 3.00213933 |
10 | * Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.63705837 |
11 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 2.62111805 |
12 | IRF1_19129219_ChIP-ChIP_H3396_Human | 2.59325886 |
13 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 2.56977211 |
14 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.30694309 |
15 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 2.30067390 |
16 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 2.29860888 |
17 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 2.29748015 |
18 | AR_21909140_ChIP-Seq_LNCAP_Human | 2.20389063 |
19 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.16468384 |
20 | CNOT3_19339689_ChIP-ChIP_MESCs_Mouse | 2.08772372 |
21 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 2.07925929 |
22 | AR_21572438_ChIP-Seq_LNCaP_Human | 2.06554894 |
23 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 2.03589765 |
24 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 2.02017352 |
25 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 2.01151849 |
26 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 2.00893523 |
27 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 1.97802642 |
28 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.94764959 |
29 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.91272888 |
30 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.90220845 |
31 | PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 1.88548461 |
32 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.86424002 |
33 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.80529995 |
34 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 1.79700836 |
35 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.78754994 |
36 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 1.77183114 |
37 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.74790545 |
38 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.73527972 |
39 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.70977174 |
40 | GATA1_26923725_Chip-Seq_HPCs_Mouse | 1.70437725 |
41 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.68447270 |
42 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.67862245 |
43 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.63701833 |
44 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.63281911 |
45 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.62267462 |
46 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.61260716 |
47 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 1.60897279 |
48 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.57779107 |
49 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.57445109 |
50 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.57339897 |
51 | * PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.51583050 |
52 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.50856890 |
53 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.49354435 |
54 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.48020861 |
55 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.46735422 |
56 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.46382574 |
57 | PKCTHETA_26484144_Chip-Seq_BREAST_Human | 1.45666614 |
58 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.45294568 |
59 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.45294568 |
60 | POU5F1_16153702_ChIP-ChIP_HESCs_Human | 1.45099611 |
61 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.45064763 |
62 | * PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 1.44653835 |
63 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.44422929 |
64 | TP53_16413492_ChIP-PET_HCT116_Human | 1.43162082 |
65 | MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 1.42771685 |
66 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.42370259 |
67 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 1.42032935 |
68 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 1.41695505 |
69 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 1.40620343 |
70 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.39632817 |
71 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 1.39501520 |
72 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.38194968 |
73 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.36559250 |
74 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.36356648 |
75 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.35518974 |
76 | KDM5B_21448134_ChIP-Seq_MESCs_Mouse | 1.34251055 |
77 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 1.34089632 |
78 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.33047370 |
79 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 1.32008796 |
80 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.31224503 |
81 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.30979948 |
82 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.30837409 |
83 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.30444728 |
84 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.29158306 |
85 | MYCN_18555785_ChIP-Seq_MESCs_Mouse | 1.29034274 |
86 | * CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 1.28140182 |
87 | SOX2_19030024_ChIP-ChIP_MESCs_Mouse | 1.27631130 |
88 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.27094492 |
89 | * GATA4_25053715_ChIP-Seq_YYC3_Human | 1.24952459 |
90 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.24937369 |
91 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.24305249 |
92 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.23929641 |
93 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.23314391 |
94 | TTF2_22483619_ChIP-Seq_HELA_Human | 1.22690544 |
95 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.21094022 |
96 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.20665225 |
97 | CREM_20920259_ChIP-Seq_GC1-SPG_Mouse | 1.20519540 |
98 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.20517219 |
99 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 1.19888218 |
100 | SALL4_18804426_ChIP-ChIP_MESCs_Mouse | 1.19519628 |
101 | TRIM28_19339689_ChIP-ChIP_MESCs_Mouse | 1.19288147 |
102 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.17626076 |
103 | MYC_18940864_ChIP-ChIP_HL60_Human | 1.16968375 |
104 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.16283064 |
105 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.15349334 |
106 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.14933145 |
107 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.14927121 |
108 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.11566970 |
109 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.11514110 |
110 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.09447087 |
111 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 1.07456866 |
112 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 1.07206337 |
113 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.06744031 |
114 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.06689738 |
115 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.06638399 |
116 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.06452376 |
117 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.06452376 |
118 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.06438755 |
119 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.06313243 |
120 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.06034337 |
121 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.05922350 |
122 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.05659090 |
123 | E2F4_21247883_ChIP-Seq_LYMPHOBLASTOID_Human | 1.05061676 |
124 | RXR_22108803_ChIP-Seq_LS180_Human | 1.04633219 |
125 | STAT1_20625510_ChIP-Seq_HELA_Human | 1.03581909 |
126 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.03239045 |
127 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.02996257 |
128 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.02298556 |
129 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.02072999 |
130 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.99918919 |
131 | SIN3A_21632747_ChIP-Seq_MESCs_Mouse | 0.99124164 |
132 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 0.98919268 |
133 | SMAD1_18555785_ChIP-Seq_MESCs_Mouse | 0.98704011 |
134 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 0.98435964 |
135 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.98064208 |
136 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 0.96011339 |
137 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 0.95605549 |
138 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.95468828 |
139 | * AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.95389440 |
140 | ELK4_26923725_Chip-Seq_MESODERM_Mouse | 0.95079717 |
141 | * PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 0.94368641 |
142 | * CJUN_26792858_Chip-Seq_BT549_Human | 0.94291115 |
143 | CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 0.92940529 |
144 | CLOCK_20551151_ChIP-Seq_293T_Human | 0.92671841 |
145 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 0.91592045 |
146 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 0.90460844 |
147 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 0.90087205 |
148 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.89482647 |
149 | * TP63_23658742_ChIP-Seq_EP156T_Human | 0.88982673 |
150 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.87729842 |
151 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 0.87719228 |
152 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.86921434 |
153 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 0.86561833 |
154 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.86413843 |
155 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.86247760 |
156 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.85978194 |
157 | ZNF274_21170338_ChIP-Seq_K562_Hela | 0.85305724 |
158 | TCF3_18692474_ChIP-Seq_MESCs_Mouse | 0.85089820 |
159 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.85072835 |
160 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 0.84991080 |
161 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 0.84887177 |
162 | TCFCP2L1_18555785_ChIP-Seq_MESCs_Mouse | 0.83676505 |
163 | GATA3_20176728_ChIP-ChIP_TSCs_Mouse | 0.83661633 |
164 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.83500429 |
165 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 0.83441186 |
166 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.83425282 |
167 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.82893586 |
168 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.82892140 |
169 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 0.82156857 |
170 | ATF3_27146783_Chip-Seq_COLON_Human | 0.82091573 |
171 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 0.81518020 |
172 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 0.81023524 |
173 | CTCF_18555785_ChIP-Seq_MESCs_Mouse | 0.80992544 |
174 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 0.80461810 |
175 | FOXM1_26100407_CHIP-SEQ_Hek293_flp-in_Human | 0.80206750 |
176 | KDM2B_26808549_Chip-Seq_K562_Human | 0.79820949 |
177 | KLF4_19030024_ChIP-ChIP_MESCs_Mouse | 0.79291397 |
178 | RCOR1_19997604_ChIP-ChIP_NEURONS_Mouse | 0.79274392 |
179 | EOMES_20176728_ChIP-ChIP_TSCs_Mouse | 0.79030894 |
180 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 0.78484922 |
181 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 0.78426359 |
182 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.78398068 |
183 | TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.76462768 |
184 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.75838733 |
185 | SOX2_18692474_ChIP-Seq_MESCs_Mouse | 0.75457883 |
186 | REST_19997604_ChIP-ChIP_NEURONS_Mouse | 0.74908670 |
187 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 0.74796896 |
188 | CHD1_26751641_Chip-Seq_LNCaP_Human | 0.74610086 |
189 | TCF3_18692474_ChIP-Seq_MEFs_Mouse | 0.73705097 |
190 | KDM5A_27292631_Chip-Seq_BREAST_Human | 0.72556328 |
191 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.72079481 |
192 | SOX2_16153702_ChIP-ChIP_HESCs_Human | 0.72066115 |
193 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 0.71851995 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0002148_abnormal_hypersensitivity_rea | 5.77565281 |
2 | MP0008004_abnormal_stomach_pH | 5.41567299 |
3 | MP0002735_abnormal_chemical_nociception | 4.52227374 |
4 | MP0009379_abnormal_foot_pigmentation | 3.92053556 |
5 | MP0002254_reproductive_system_inflammat | 3.76497883 |
6 | MP0003436_decreased_susceptibility_to | 3.67921524 |
7 | MP0005257_abnormal_intraocular_pressure | 3.58652315 |
8 | MP0002098_abnormal_vibrissa_morphology | 3.21192390 |
9 | MP0003195_calcinosis | 3.08560527 |
10 | MP0000427_abnormal_hair_cycle | 2.87537463 |
11 | MP0000516_abnormal_urinary_system | 2.86440644 |
12 | MP0005367_renal/urinary_system_phenotyp | 2.86440644 |
13 | MP0003123_paternal_imprinting | 2.84883896 |
14 | MP0010352_gastrointestinal_tract_polyps | 2.65224574 |
15 | MP0005000_abnormal_immune_tolerance | 2.58407756 |
16 | MP0002009_preneoplasia | 2.57563780 |
17 | MP0003303_peritoneal_inflammation | 2.39863506 |
18 | MP0003693_abnormal_embryo_hatching | 2.38881672 |
19 | MP0001835_abnormal_antigen_presentation | 2.30811459 |
20 | MP0008057_abnormal_DNA_replication | 2.26351405 |
21 | MP0000490_abnormal_crypts_of | 2.26153618 |
22 | MP0010155_abnormal_intestine_physiology | 2.21275197 |
23 | MP0010678_abnormal_skin_adnexa | 2.19894715 |
24 | * MP0001986_abnormal_taste_sensitivity | 2.19841976 |
25 | MP0000538_abnormal_urinary_bladder | 2.05169440 |
26 | MP0002092_abnormal_eye_morphology | 1.99040769 |
27 | MP0005551_abnormal_eye_electrophysiolog | 1.96391382 |
28 | MP0002168_other_aberrant_phenotype | 1.94906068 |
29 | MP0001346_abnormal_lacrimal_gland | 1.89381750 |
30 | MP0002796_impaired_skin_barrier | 1.88677988 |
31 | MP0003638_abnormal_response/metabolism_ | 1.86940994 |
32 | MP0002405_respiratory_system_inflammati | 1.85205061 |
33 | MP0002876_abnormal_thyroid_physiology | 1.83756778 |
34 | MP0006082_CNS_inflammation | 1.83193685 |
35 | MP0003300_gastrointestinal_ulcer | 1.81654971 |
36 | MP0005501_abnormal_skin_physiology | 1.80967511 |
37 | MP0005464_abnormal_platelet_physiology | 1.79403092 |
38 | MP0010234_abnormal_vibrissa_follicle | 1.78608004 |
39 | MP0005310_abnormal_salivary_gland | 1.77531440 |
40 | MP0004510_myositis | 1.76199932 |
41 | MP0000685_abnormal_immune_system | 1.75435592 |
42 | MP0000579_abnormal_nail_morphology | 1.74244396 |
43 | MP0010386_abnormal_urinary_bladder | 1.72571491 |
44 | MP0002734_abnormal_mechanical_nocicepti | 1.71801280 |
45 | MP0005253_abnormal_eye_physiology | 1.69912630 |
46 | MP0002419_abnormal_innate_immunity | 1.68358327 |
47 | MP0003075_altered_response_to | 1.66455897 |
48 | MP0003890_abnormal_embryonic-extraembry | 1.65695929 |
49 | MP0001533_abnormal_skeleton_physiology | 1.64043966 |
50 | MP0003705_abnormal_hypodermis_morpholog | 1.63307142 |
51 | MP0005025_abnormal_response_to | 1.60436429 |
52 | MP0004957_abnormal_blastocyst_morpholog | 1.59390067 |
53 | MP0001800_abnormal_humoral_immune | 1.58687863 |
54 | MP0001790_abnormal_immune_system | 1.58042745 |
55 | MP0005387_immune_system_phenotype | 1.58042745 |
56 | MP0000377_abnormal_hair_follicle | 1.55075875 |
57 | MP0005395_other_phenotype | 1.54675773 |
58 | MP0001845_abnormal_inflammatory_respons | 1.53373600 |
59 | MP0005671_abnormal_response_to | 1.52802773 |
60 | MP0004264_abnormal_extraembryonic_tissu | 1.47027094 |
61 | MP0002452_abnormal_antigen_presenting | 1.45081181 |
62 | MP0000383_abnormal_hair_follicle | 1.43952891 |
63 | MP0003385_abnormal_body_wall | 1.43868661 |
64 | MP0004134_abnormal_chest_morphology | 1.39448165 |
65 | MP0000537_abnormal_urethra_morphology | 1.38807998 |
66 | MP0002111_abnormal_tail_morphology | 1.36736374 |
67 | MP0001984_abnormal_olfaction | 1.36560119 |
68 | MP0005423_abnormal_somatic_nervous | 1.36521918 |
69 | MP0002822_catalepsy | 1.36430938 |
70 | MP0009764_decreased_sensitivity_to | 1.36239589 |
71 | MP0003724_increased_susceptibility_to | 1.35140829 |
72 | MP0002723_abnormal_immune_serum | 1.34252846 |
73 | MP0002060_abnormal_skin_morphology | 1.33357601 |
74 | MP0002733_abnormal_thermal_nociception | 1.32835129 |
75 | MP0005023_abnormal_wound_healing | 1.32651168 |
76 | MP0004130_abnormal_muscle_cell | 1.32529067 |
77 | MP0005645_abnormal_hypothalamus_physiol | 1.30188219 |
78 | MP0009785_altered_susceptibility_to | 1.29642714 |
79 | MP0002736_abnormal_nociception_after | 1.29328373 |
80 | MP0001849_ear_inflammation | 1.28786953 |
81 | MP0001819_abnormal_immune_cell | 1.26738473 |
82 | MP0005166_decreased_susceptibility_to | 1.25428543 |
83 | MP0002420_abnormal_adaptive_immunity | 1.23311189 |
84 | MP0001188_hyperpigmentation | 1.22512165 |
85 | MP0010094_abnormal_chromosome_stability | 1.21887657 |
86 | MP0003172_abnormal_lysosome_physiology | 1.20720148 |
87 | MP0001348_abnormal_lacrimal_gland | 1.20610532 |
88 | MP0008469_abnormal_protein_level | 1.16957521 |
89 | MP0005365_abnormal_bile_salt | 1.15721200 |
90 | MP0002295_abnormal_pulmonary_circulatio | 1.15028439 |
91 | MP0000762_abnormal_tongue_morphology | 1.14403802 |
92 | MP0003077_abnormal_cell_cycle | 1.13920791 |
93 | MP0003566_abnormal_cell_adhesion | 1.13205845 |
94 | MP0010771_integument_phenotype | 1.12837301 |
95 | MP0005058_abnormal_lysosome_morphology | 1.12063522 |
96 | MP0002163_abnormal_gland_morphology | 1.11109439 |
97 | MP0000534_abnormal_ureter_morphology | 1.10992205 |
98 | MP0009763_increased_sensitivity_to | 1.10848261 |
99 | MP0003315_abnormal_perineum_morphology | 1.09458176 |
100 | MP0001851_eye_inflammation | 1.07719364 |
101 | MP0000343_altered_response_to | 1.07376863 |
102 | MP0003937_abnormal_limbs/digits/tail_de | 1.07273584 |
103 | MP0000955_abnormal_spinal_cord | 1.06951638 |
104 | MP0001727_abnormal_embryo_implantation | 1.05861451 |
105 | MP0001216_abnormal_epidermal_layer | 1.05668267 |
106 | MP0003045_fibrosis | 1.05038460 |
107 | MP0006072_abnormal_retinal_apoptosis | 1.04992632 |
108 | MP0000013_abnormal_adipose_tissue | 1.02838766 |
109 | MP0004019_abnormal_vitamin_homeostasis | 1.02781229 |
110 | MP0003943_abnormal_hepatobiliary_system | 1.02360966 |
111 | MP0001666_abnormal_nutrient_absorption | 1.01889414 |
112 | MP0002928_abnormal_bile_duct | 1.00922337 |
113 | MP0009765_abnormal_xenobiotic_induced | 1.00749660 |
114 | MP0004782_abnormal_surfactant_physiolog | 1.00695810 |
115 | MP0005379_endocrine/exocrine_gland_phen | 1.00629574 |
116 | MP0002084_abnormal_developmental_patter | 1.00291498 |
117 | MP0005391_vision/eye_phenotype | 0.99266894 |
118 | MP0001853_heart_inflammation | 0.96811845 |
119 | MP0003011_delayed_dark_adaptation | 0.96045550 |
120 | MP0002697_abnormal_eye_size | 0.96022967 |
121 | MP0003718_maternal_effect | 0.95902783 |
122 | MP0004858_abnormal_nervous_system | 0.93653122 |
123 | MP0001968_abnormal_touch/_nociception | 0.92183320 |
124 | MP0003111_abnormal_nucleus_morphology | 0.91311608 |
125 | MP0003806_abnormal_nucleotide_metabolis | 0.91074628 |
126 | MP0010329_abnormal_lipoprotein_level | 0.89821842 |
127 | MP0001970_abnormal_pain_threshold | 0.88728652 |
128 | MP0003787_abnormal_imprinting | 0.88308624 |
129 | MP0002234_abnormal_pharynx_morphology | 0.86881235 |
130 | MP0003755_abnormal_palate_morphology | 0.86620158 |
131 | MP0003950_abnormal_plasma_membrane | 0.85826236 |
132 | MP0003119_abnormal_digestive_system | 0.85439231 |
133 | MP0002909_abnormal_adrenal_gland | 0.84819324 |
134 | MP0005197_abnormal_uvea_morphology | 0.84677018 |
135 | MP0002877_abnormal_melanocyte_morpholog | 0.84497095 |
136 | MP0008874_decreased_physiological_sensi | 0.83831164 |
137 | MP0002116_abnormal_craniofacial_bone | 0.83380013 |
138 | MP0003221_abnormal_cardiomyocyte_apopto | 0.80429106 |
139 | MP0001765_abnormal_ion_homeostasis | 0.79670133 |
140 | MP0008058_abnormal_DNA_repair | 0.79269041 |
141 | MP0003448_altered_tumor_morphology | 0.78468976 |
142 | MP0002166_altered_tumor_susceptibility | 0.77934668 |
143 | MP0004036_abnormal_muscle_relaxation | 0.77419672 |
144 | MP0002233_abnormal_nose_morphology | 0.76679762 |
145 | MP0002006_tumorigenesis | 0.76366592 |
146 | MP0009643_abnormal_urine_homeostasis | 0.75619553 |
147 | MP0006035_abnormal_mitochondrial_morpho | 0.75492140 |
148 | MP0005409_darkened_coat_color | 0.75157205 |
149 | MP0005084_abnormal_gallbladder_morpholo | 0.73801609 |
150 | MP0001672_abnormal_embryogenesis/_devel | 0.73704432 |
151 | MP0005380_embryogenesis_phenotype | 0.73704432 |
152 | MP0002896_abnormal_bone_mineralization | 0.73339284 |
153 | MP0004742_abnormal_vestibular_system | 0.72723700 |
154 | MP0008932_abnormal_embryonic_tissue | 0.72004434 |
155 | MP0000767_abnormal_smooth_muscle | 0.71873126 |
156 | MP0005390_skeleton_phenotype | 0.71697867 |
157 | MP0009780_abnormal_chondrocyte_physiolo | 0.71409590 |
158 | MP0005164_abnormal_response_to | 0.71102007 |
159 | MP0000470_abnormal_stomach_morphology | 0.71069815 |
160 | MP0002184_abnormal_innervation | 0.71057508 |
161 | MP0001293_anophthalmia | 0.69772248 |
162 | MP0004185_abnormal_adipocyte_glucose | 0.68698999 |
163 | MP0003329_amyloid_beta_deposits | 0.68193671 |
164 | MP0000477_abnormal_intestine_morphology | 0.67386808 |
165 | MP0004947_skin_inflammation | 0.67325068 |
166 | MP0003453_abnormal_keratinocyte_physiol | 0.66926901 |
167 | MP0003091_abnormal_cell_migration | 0.66660670 |
168 | MP0001529_abnormal_vocalization | 0.66539152 |
169 | MP0000627_abnormal_mammary_gland | 0.66472372 |
170 | MP0002138_abnormal_hepatobiliary_system | 0.66042856 |
171 | MP0004484_altered_response_of | 0.65994314 |
172 | MP0005195_abnormal_posterior_eye | 0.65500628 |
173 | MP0003880_abnormal_central_pattern | 0.65344322 |
174 | MP0002837_dystrophic_cardiac_calcinosis | 0.65280237 |
175 | MP0002090_abnormal_vision | 0.65142088 |
176 | MP0000432_abnormal_head_morphology | 0.63213337 |
177 | MP0006138_congestive_heart_failure | 0.62618345 |
178 | MP0003984_embryonic_growth_retardation | 0.62250437 |
179 | MP0005360_urolithiasis | 0.61337622 |
180 | MP0002085_abnormal_embryonic_tissue | 0.61195229 |
181 | MP0000358_abnormal_cell_content/ | 0.60591877 |
182 | MP0000747_muscle_weakness | 0.60407268 |
183 | MP0000566_synostosis | 0.60080703 |
184 | MP0004270_analgesia | 0.60079780 |
185 | MP0001697_abnormal_embryo_size | 0.59775917 |
186 | MP0003861_abnormal_nervous_system | 0.59391653 |
187 | MP0002088_abnormal_embryonic_growth/wei | 0.59134288 |
188 | MP0002160_abnormal_reproductive_system | 0.58525110 |
189 | MP0002752_abnormal_somatic_nervous | 0.57624383 |
190 | MP0005193_abnormal_anterior_eye | 0.57231956 |
191 | MP0009053_abnormal_anal_canal | 0.56353172 |
192 | MP0008775_abnormal_heart_ventricle | 0.56019141 |
193 | MP0000681_abnormal_thyroid_gland | 0.55110408 |
194 | MP0002882_abnormal_neuron_morphology | 0.54937708 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Congenital stationary night blindness (HP:0007642) | 9.30215074 |
2 | Insomnia (HP:0100785) | 8.50671572 |
3 | Right ventricular cardiomyopathy (HP:0011663) | 5.98069470 |
4 | Pili torti (HP:0003777) | 5.89046346 |
5 | Diaphragmatic weakness (HP:0009113) | 5.28696961 |
6 | Sex reversal (HP:0012245) | 5.21755938 |
7 | Abnormal sex determination (HP:0012244) | 5.21755938 |
8 | Oligodontia (HP:0000677) | 5.20414629 |
9 | Decreased central vision (HP:0007663) | 5.14471853 |
10 | Recurrent gram-negative bacterial infections (HP:0005420) | 4.84702079 |
11 | Aplasia cutis congenita (HP:0001057) | 4.74168542 |
12 | Sparse scalp hair (HP:0002209) | 4.58526767 |
13 | Elfin facies (HP:0004428) | 4.56408317 |
14 | Overriding aorta (HP:0002623) | 4.41713507 |
15 | Pigmentary retinal degeneration (HP:0001146) | 4.35093681 |
16 | Leiomyosarcoma (HP:0100243) | 4.31027163 |
17 | Uterine leiomyosarcoma (HP:0002891) | 4.31027163 |
18 | Microglossia (HP:0000171) | 4.29668841 |
19 | Anhidrosis (HP:0000970) | 4.17030030 |
20 | Hyperacusis (HP:0010780) | 4.10881810 |
21 | Premature loss of primary teeth (HP:0006323) | 4.01683172 |
22 | True hermaphroditism (HP:0010459) | 4.00707842 |
23 | Abnormality of the gastric mucosa (HP:0004295) | 3.97052645 |
24 | Renovascular hypertension (HP:0100817) | 3.81930341 |
25 | Hereditary nonpolyposis colorectal carcinoma (HP:0006716) | 3.79894530 |
26 | Transitional cell carcinoma of the bladder (HP:0006740) | 3.74437732 |
27 | Abnormality of the parietal bone (HP:0002696) | 3.74434303 |
28 | Dysmetric saccades (HP:0000641) | 3.71292031 |
29 | Interstitial pulmonary disease (HP:0006530) | 3.70090835 |
30 | Renal duplication (HP:0000075) | 3.69694743 |
31 | Premature skin wrinkling (HP:0100678) | 3.67875535 |
32 | Ankyloglossia (HP:0010296) | 3.60997079 |
33 | Bladder carcinoma (HP:0002862) | 3.59926858 |
34 | Bladder neoplasm (HP:0009725) | 3.59926858 |
35 | Confusion (HP:0001289) | 3.54051237 |
36 | Sparse eyelashes (HP:0000653) | 3.53497734 |
37 | Adrenal hypoplasia (HP:0000835) | 3.40022745 |
38 | Malignant gastrointestinal tract tumors (HP:0006749) | 3.35766243 |
39 | Gastrointestinal carcinoma (HP:0002672) | 3.35766243 |
40 | Esophageal varix (HP:0002040) | 3.28874315 |
41 | Recurrent abscess formation (HP:0002722) | 3.21597127 |
42 | Eczematoid dermatitis (HP:0000976) | 3.20988814 |
43 | Attenuation of retinal blood vessels (HP:0007843) | 3.20001351 |
44 | Neonatal short-limb short stature (HP:0008921) | 3.14582931 |
45 | Flat cornea (HP:0007720) | 3.14231280 |
46 | Neoplasm of the colon (HP:0100273) | 3.13580855 |
47 | Abnormal hair laboratory examination (HP:0003328) | 3.13044634 |
48 | Chronic sinusitis (HP:0011109) | 3.12623848 |
49 | 11 pairs of ribs (HP:0000878) | 3.08282983 |
50 | Abnormality of liposaccharide metabolism (HP:0010968) | 3.06894015 |
51 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 3.06894015 |
52 | Abnormality of glycolipid metabolism (HP:0010969) | 3.06894015 |
53 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 3.06790839 |
54 | Amniotic constriction ring (HP:0009775) | 3.06669431 |
55 | Abnormality of placental membranes (HP:0011409) | 3.06669431 |
56 | Hypotrichosis (HP:0001006) | 3.03260162 |
57 | Long clavicles (HP:0000890) | 2.97963896 |
58 | Macular degeneration (HP:0000608) | 2.97741216 |
59 | Abnormal rod and cone electroretinograms (HP:0008323) | 2.96073527 |
60 | Megalocornea (HP:0000485) | 2.93047078 |
61 | Abnormality of the diencephalon (HP:0010662) | 2.87830860 |
62 | Progressive neurologic deterioration (HP:0002344) | 2.86567690 |
63 | Widely patent fontanelles and sutures (HP:0004492) | 2.85282694 |
64 | Thick nail (HP:0001805) | 2.83499794 |
65 | Intestinal polyposis (HP:0200008) | 2.83208684 |
66 | Hypokinesia (HP:0002375) | 2.83177420 |
67 | Recurrent bacterial skin infections (HP:0005406) | 2.81920211 |
68 | Vertebral compression fractures (HP:0002953) | 2.80971976 |
69 | Poikiloderma (HP:0001029) | 2.80714886 |
70 | Reticulocytopenia (HP:0001896) | 2.79902316 |
71 | Gait imbalance (HP:0002141) | 2.78772044 |
72 | Increased IgM level (HP:0003496) | 2.78327101 |
73 | Congenital primary aphakia (HP:0007707) | 2.77523619 |
74 | Ketoacidosis (HP:0001993) | 2.74349235 |
75 | Abnormality of oral frenula (HP:0000190) | 2.72179454 |
76 | Short clavicles (HP:0000894) | 2.71733147 |
77 | Intestinal polyp (HP:0005266) | 2.64511829 |
78 | Micronodular cirrhosis (HP:0001413) | 2.60294004 |
79 | Bronchomalacia (HP:0002780) | 2.57463991 |
80 | Renal cell carcinoma (HP:0005584) | 2.56613441 |
81 | Vascular calcification (HP:0004934) | 2.55395272 |
82 | Atrophic scars (HP:0001075) | 2.53632269 |
83 | Pustule (HP:0200039) | 2.51716264 |
84 | Thin skin (HP:0000963) | 2.51489964 |
85 | Bony spicule pigmentary retinopathy (HP:0007737) | 2.50083375 |
86 | Increased nuchal translucency (HP:0010880) | 2.48459467 |
87 | Distal lower limb muscle weakness (HP:0009053) | 2.47579698 |
88 | Gingivitis (HP:0000230) | 2.47108157 |
89 | Dyschromatopsia (HP:0007641) | 2.46976058 |
90 | Palmoplantar hyperkeratosis (HP:0000972) | 2.44322734 |
91 | Mediastinal lymphadenopathy (HP:0100721) | 2.41789093 |
92 | Osteolytic defects of the hand bones (HP:0009699) | 2.41207483 |
93 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.41207483 |
94 | Palmar hyperkeratosis (HP:0010765) | 2.40998604 |
95 | Ulnar claw (HP:0001178) | 2.40481738 |
96 | Uterine neoplasm (HP:0010784) | 2.38993435 |
97 | Supranuclear gaze palsy (HP:0000605) | 2.38313686 |
98 | Microdontia (HP:0000691) | 2.38108594 |
99 | High anterior hairline (HP:0009890) | 2.36218251 |
100 | Mitral stenosis (HP:0001718) | 2.36135799 |
101 | Prolonged QT interval (HP:0001657) | 2.35780063 |
102 | Dysostosis multiplex (HP:0000943) | 2.35667127 |
103 | Cardiovascular calcification (HP:0011915) | 2.34565345 |
104 | Cone-rod dystrophy (HP:0000548) | 2.33822629 |
105 | Axonal loss (HP:0003447) | 2.33410470 |
106 | Aplasia/Hypoplasia of the clavicles (HP:0006710) | 2.33258198 |
107 | Nephrogenic diabetes insipidus (HP:0009806) | 2.31231639 |
108 | Abnormality of cells of the erythroid lineage (HP:0012130) | 2.29746759 |
109 | Milia (HP:0001056) | 2.28330897 |
110 | Redundant skin (HP:0001582) | 2.26931136 |
111 | Ventricular arrhythmia (HP:0004308) | 2.26716928 |
112 | Delusions (HP:0000746) | 2.25832765 |
113 | Medial flaring of the eyebrow (HP:0010747) | 2.25607477 |
114 | Respiratory distress (HP:0002098) | 2.20674624 |
115 | Abnormality of hair growth rate (HP:0011363) | 2.20339137 |
116 | Slow-growing hair (HP:0002217) | 2.20339137 |
117 | Abnormality of macrophages (HP:0004311) | 2.19870548 |
118 | Retinal atrophy (HP:0001105) | 2.19290895 |
119 | Generalized hyperpigmentation (HP:0007440) | 2.19038222 |
120 | Thickened calvaria (HP:0002684) | 2.17635507 |
121 | Pulmonary infiltrates (HP:0002113) | 2.17571847 |
122 | Onycholysis (HP:0001806) | 2.16021278 |
123 | Hyponatremia (HP:0002902) | 2.13414900 |
124 | Syncope (HP:0001279) | 2.12035074 |
125 | Malignant hyperthermia (HP:0002047) | 2.11507247 |
126 | Abnormality of renal resorption (HP:0011038) | 2.10768231 |
127 | Plantar hyperkeratosis (HP:0007556) | 2.10248725 |
128 | Aplasia/Hypoplasia of the sacrum (HP:0008517) | 2.08252388 |
129 | Bowel diverticulosis (HP:0005222) | 2.07166443 |
130 | Glucose intolerance (HP:0000833) | 2.07160223 |
131 | Hypercalciuria (HP:0002150) | 2.05376638 |
132 | Periodontitis (HP:0000704) | 2.04181513 |
133 | Retinitis pigmentosa (HP:0000510) | 2.03091778 |
134 | Microvesicular hepatic steatosis (HP:0001414) | 2.03005768 |
135 | Vaginal atresia (HP:0000148) | 2.01795022 |
136 | Abdominal distention (HP:0003270) | 2.01210446 |
137 | Limb hypertonia (HP:0002509) | 2.00741934 |
138 | Termporal pattern (HP:0011008) | 2.00281829 |
139 | Insidious onset (HP:0003587) | 2.00281829 |
140 | Wide cranial sutures (HP:0010537) | 1.97314212 |
141 | Ridged nail (HP:0001807) | 1.96933739 |
142 | Short nail (HP:0001799) | 1.94935060 |
143 | Poor coordination (HP:0002370) | 1.94904818 |
144 | Sudden cardiac death (HP:0001645) | 1.94211900 |
145 | Genital tract atresia (HP:0001827) | 1.92820556 |
146 | Lip pit (HP:0100267) | 1.92345123 |
147 | Elevated erythrocyte sedimentation rate (HP:0003565) | 1.92269036 |
148 | Pointed chin (HP:0000307) | 1.88763134 |
149 | Tibial bowing (HP:0002982) | 1.88148335 |
150 | Abnormality of male internal genitalia (HP:0000022) | 1.88092968 |
151 | Progressive external ophthalmoplegia (HP:0000590) | 1.87810293 |
152 | Photophobia (HP:0000613) | 1.87730127 |
153 | Mucopolysacchariduria (HP:0008155) | 1.86897818 |
154 | Urinary glycosaminoglycan excretion (HP:0003541) | 1.86897818 |
155 | Hand muscle atrophy (HP:0009130) | 1.85404873 |
156 | Ragged-red muscle fibers (HP:0003200) | 1.85289891 |
157 | Segmental peripheral demyelination/remyelination (HP:0003481) | 1.85211546 |
158 | Missing ribs (HP:0000921) | 1.85208659 |
159 | Delayed CNS myelination (HP:0002188) | 1.85009015 |
160 | Abnormality of proline metabolism (HP:0010907) | 1.82480578 |
161 | Hydroxyprolinuria (HP:0003080) | 1.82480578 |
162 | Congenital, generalized hypertrichosis (HP:0004540) | 1.81711425 |
163 | Purpura (HP:0000979) | 1.81431073 |
164 | Tachypnea (HP:0002789) | 1.80497349 |
165 | Abnormality of the right ventricle (HP:0001707) | 1.80382219 |
166 | Recurrent skin infections (HP:0001581) | 1.79871067 |
167 | Systemic lupus erythematosus (HP:0002725) | 1.78732159 |
168 | Abnormality of the sella turcica (HP:0002679) | 1.78234476 |
169 | Type II diabetes mellitus (HP:0005978) | 1.76817226 |
170 | Hypoplastic toenails (HP:0001800) | 1.76502120 |
171 | Abnormality of the neuromuscular junction (HP:0003398) | 1.75719423 |
172 | Fatigable weakness (HP:0003473) | 1.75719423 |
173 | Focal motor seizures (HP:0011153) | 1.74709963 |
174 | Myokymia (HP:0002411) | 1.73776501 |
175 | Increased mean platelet volume (HP:0011877) | 1.73584832 |
176 | Focal segmental glomerulosclerosis (HP:0000097) | 1.73511358 |
177 | Abnormality of the carotid arteries (HP:0005344) | 1.73123564 |
178 | Metaphyseal dysplasia (HP:0100255) | 1.73042525 |
179 | Abnormal glucose tolerance (HP:0001952) | 1.72565458 |
180 | Abnormality of primary teeth (HP:0006481) | 1.72359563 |
181 | Abnormality of the preputium (HP:0100587) | 1.71899945 |
182 | Autoimmune thrombocytopenia (HP:0001973) | 1.71793203 |
183 | Hypergammaglobulinemia (HP:0010702) | 1.69516572 |
184 | Recurrent bronchitis (HP:0002837) | 1.69136786 |
185 | Aplasia/Hypoplasia of the lens (HP:0008063) | 1.68846061 |
186 | Tetany (HP:0001281) | 1.68721784 |
187 | Hypoplasia of dental enamel (HP:0006297) | 1.68526483 |
188 | Abnormality of polysaccharide metabolism (HP:0011012) | 1.68494053 |
189 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 1.68494053 |
190 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 1.68494053 |
191 | Abnormalities of placenta or umbilical cord (HP:0001194) | 1.68293821 |
192 | Cheilitis (HP:0100825) | 1.66994643 |
193 | Bundle branch block (HP:0011710) | 1.66922045 |
194 | Hypercalcemia (HP:0003072) | 1.66652273 |
195 | Growth hormone excess (HP:0000845) | 1.65063141 |
Rank | Gene Set | Z-score |
---|---|---|
1 | EEF2K | 6.01375821 |
2 | ERBB3 | 5.30271322 |
3 | MAPKAPK5 | 4.62821658 |
4 | ZAK | 3.78232188 |
5 | PIK3CG | 3.35900859 |
6 | KSR2 | 3.30642456 |
7 | PBK | 3.00064054 |
8 | MKNK1 | 2.96617315 |
9 | LATS2 | 2.95721882 |
10 | STK39 | 2.79725856 |
11 | TLK1 | 2.76118444 |
12 | TRPM7 | 2.71278753 |
13 | RAF1 | 2.69876083 |
14 | NME1 | 2.64679490 |
15 | MAPK15 | 2.64245994 |
16 | STK38L | 2.47160217 |
17 | SCYL2 | 2.46520122 |
18 | PHKG2 | 2.41235863 |
19 | PHKG1 | 2.41235863 |
20 | INSRR | 2.27082384 |
21 | EPHA2 | 2.23833615 |
22 | BMPR1B | 2.23794508 |
23 | RPS6KB2 | 2.21649348 |
24 | DMPK | 2.18668321 |
25 | SIK1 | 2.16870365 |
26 | BRAF | 2.10191948 |
27 | TBK1 | 2.08041706 |
28 | MAP3K10 | 2.01551766 |
29 | LATS1 | 1.99163721 |
30 | TEC | 1.98718425 |
31 | KSR1 | 1.90658975 |
32 | BMPR2 | 1.73064401 |
33 | ARAF | 1.68525301 |
34 | BLK | 1.67045222 |
35 | CDK3 | 1.66675503 |
36 | ERN1 | 1.59840667 |
37 | TTK | 1.58996951 |
38 | MAP3K14 | 1.57005381 |
39 | RPS6KA5 | 1.55490463 |
40 | EIF2AK1 | 1.54492686 |
41 | EIF2AK3 | 1.53795869 |
42 | MAP3K13 | 1.52892324 |
43 | BTK | 1.49153992 |
44 | MELK | 1.47091936 |
45 | IRAK2 | 1.45240034 |
46 | TYK2 | 1.42391448 |
47 | WNK3 | 1.42017917 |
48 | TAOK3 | 1.37027893 |
49 | MUSK | 1.35861876 |
50 | RIPK4 | 1.34710721 |
51 | MINK1 | 1.32933396 |
52 | EPHA4 | 1.31054150 |
53 | ITK | 1.28308812 |
54 | SRPK1 | 1.27190936 |
55 | CASK | 1.25047279 |
56 | PRKCI | 1.20607839 |
57 | OXSR1 | 1.20095613 |
58 | NEK2 | 1.16917684 |
59 | MAP3K12 | 1.16892392 |
60 | CCNB1 | 1.16137234 |
61 | MAP2K1 | 1.14972402 |
62 | PRPF4B | 1.14822690 |
63 | IKBKB | 1.13434480 |
64 | IKBKE | 1.12819818 |
65 | IRAK1 | 1.11847773 |
66 | PAK6 | 1.11573050 |
67 | CDC7 | 1.10337755 |
68 | SMG1 | 1.07453329 |
69 | AKT3 | 1.06929668 |
70 | MAP3K2 | 1.00675697 |
71 | TRIB3 | 0.97395729 |
72 | MAP3K9 | 0.96366366 |
73 | TSSK6 | 0.96242159 |
74 | MAPKAPK2 | 0.96101761 |
75 | NEK1 | 0.94532128 |
76 | EIF2AK2 | 0.91490573 |
77 | CSNK1G3 | 0.91465894 |
78 | STK3 | 0.91114865 |
79 | PAK3 | 0.88740906 |
80 | PASK | 0.88411785 |
81 | CDK19 | 0.88059289 |
82 | STK24 | 0.85371150 |
83 | NEK6 | 0.81999349 |
84 | CSNK1A1L | 0.80033940 |
85 | PLK1 | 0.79449285 |
86 | CHUK | 0.79019447 |
87 | TGFBR1 | 0.78921554 |
88 | DYRK3 | 0.78311943 |
89 | CHEK2 | 0.77413169 |
90 | RPS6KB1 | 0.76867010 |
91 | ABL2 | 0.76337837 |
92 | WEE1 | 0.74942606 |
93 | MATK | 0.72871551 |
94 | CSNK1G1 | 0.72732062 |
95 | KIT | 0.72452296 |
96 | EPHB1 | 0.71978773 |
97 | PTK2 | 0.71584691 |
98 | LMTK2 | 0.71519550 |
99 | CSNK1G2 | 0.71033445 |
100 | HCK | 0.70792513 |
101 | NTRK3 | 0.69010220 |
102 | PRKCQ | 0.68741431 |
103 | SYK | 0.68497332 |
104 | MAPK7 | 0.66144845 |
105 | CSNK1E | 0.66024456 |
106 | CSF1R | 0.65795134 |
107 | CAMK2A | 0.65357610 |
108 | PRKG2 | 0.62539769 |
109 | BUB1 | 0.62210024 |
110 | PKN2 | 0.61791424 |
111 | JAK2 | 0.60982847 |
112 | AURKB | 0.57423886 |
113 | TGFBR2 | 0.55823190 |
114 | CDK8 | 0.54529812 |
115 | STK16 | 0.54380631 |
116 | PRKAA1 | 0.53580641 |
117 | PRKCD | 0.53094944 |
118 | AURKA | 0.52450383 |
119 | NUAK1 | 0.52218195 |
120 | TYRO3 | 0.51019249 |
121 | IRAK3 | 0.50166567 |
122 | DAPK3 | 0.48896322 |
123 | RPS6KA2 | 0.47070338 |
124 | NEK9 | 0.45642604 |
125 | PKN1 | 0.45216638 |
126 | LRRK2 | 0.43931081 |
127 | BCR | 0.42936398 |
128 | TAF1 | 0.42377440 |
129 | CSK | 0.40837284 |
130 | PTK6 | 0.40236147 |
131 | VRK1 | 0.39021306 |
132 | MAP2K2 | 0.38887402 |
133 | IGF1R | 0.38203782 |
134 | WNK4 | 0.38054155 |
135 | IRAK4 | 0.37249782 |
136 | MST1R | 0.36749813 |
137 | PRKACG | 0.36729939 |
138 | MAP3K1 | 0.36317267 |
139 | ATR | 0.36219200 |
140 | CSNK2A2 | 0.36165290 |
141 | RPS6KA4 | 0.36041427 |
142 | CAMK2G | 0.35480675 |
143 | PRKCZ | 0.35105824 |
144 | EGFR | 0.34918309 |
145 | MAP4K1 | 0.34265287 |
146 | MAPK4 | 0.34049514 |
147 | RPS6KA1 | 0.33485407 |
148 | PLK3 | 0.33430769 |
149 | STK38 | 0.31911031 |
150 | MST4 | 0.31595712 |
151 | PRKCH | 0.30477275 |
152 | CDK15 | 0.30104417 |
153 | MAPKAPK3 | 0.30023427 |
154 | PIM2 | 0.29008319 |
155 | TTN | 0.28836012 |
156 | CAMK1D | 0.28745126 |
157 | MET | 0.28328566 |
158 | CDK18 | 0.28239931 |
159 | ABL1 | 0.28067783 |
160 | CDK2 | 0.27359109 |
161 | MAP3K8 | 0.27016222 |
162 | CDK11A | 0.26443220 |
163 | MOS | 0.24672502 |
164 | GRK1 | 0.24244925 |
165 | CAMK1 | 0.24180029 |
166 | PRKCA | 0.23939728 |
167 | PRKCE | 0.23690369 |
168 | NME2 | 0.23385500 |
169 | JAK1 | 0.22698321 |
170 | PRKACA | 0.21368640 |
171 | LYN | 0.20170301 |
172 | ADRBK2 | 0.19790386 |
173 | RPS6KA6 | 0.19023476 |
174 | SRC | 0.18383846 |
175 | ERBB2 | 0.18140666 |
176 | CDC42BPA | 0.18000979 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Phototransduction_Homo sapiens_hsa04744 | 5.96311630 |
2 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 5.35586143 |
3 | Alcoholism_Homo sapiens_hsa05034 | 4.44929043 |
4 | Ribosome_Homo sapiens_hsa03010 | 4.15244705 |
5 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 3.44670885 |
6 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 3.36559179 |
7 | Basal cell carcinoma_Homo sapiens_hsa05217 | 2.90023905 |
8 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 2.62324929 |
9 | Endometrial cancer_Homo sapiens_hsa05213 | 2.60201659 |
10 | Leishmaniasis_Homo sapiens_hsa05140 | 2.44959888 |
11 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 2.29778399 |
12 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 2.19680858 |
13 | DNA replication_Homo sapiens_hsa03030 | 2.16750673 |
14 | Malaria_Homo sapiens_hsa05144 | 2.09557678 |
15 | Colorectal cancer_Homo sapiens_hsa05210 | 2.05593817 |
16 | Hippo signaling pathway_Homo sapiens_hsa04390 | 2.05545093 |
17 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 2.03515827 |
18 | Wnt signaling pathway_Homo sapiens_hsa04310 | 2.01649273 |
19 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.88514779 |
20 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.73865837 |
21 | Mismatch repair_Homo sapiens_hsa03430 | 1.71944912 |
22 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 1.62782104 |
23 | Asthma_Homo sapiens_hsa05310 | 1.59554495 |
24 | Viral carcinogenesis_Homo sapiens_hsa05203 | 1.58869880 |
25 | Cell cycle_Homo sapiens_hsa04110 | 1.58504953 |
26 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.58281309 |
27 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.57890958 |
28 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.54831328 |
29 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.53216682 |
30 | Non-homologous end-joining_Homo sapiens_hsa03450 | 1.50689706 |
31 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.48849418 |
32 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.47120995 |
33 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 1.42042487 |
34 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.41012491 |
35 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.40468691 |
36 | Nucleotide excision repair_Homo sapiens_hsa03420 | 1.37014026 |
37 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.36865060 |
38 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 1.35872402 |
39 | Amoebiasis_Homo sapiens_hsa05146 | 1.34873170 |
40 | Tuberculosis_Homo sapiens_hsa05152 | 1.33291732 |
41 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.32323778 |
42 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.32279048 |
43 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.30867972 |
44 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.30672321 |
45 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 1.28026487 |
46 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.26906298 |
47 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.25942257 |
48 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 1.21877465 |
49 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.21048148 |
50 | VEGF signaling pathway_Homo sapiens_hsa04370 | 1.20136748 |
51 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 1.19121738 |
52 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.17877401 |
53 | Allograft rejection_Homo sapiens_hsa05330 | 1.16998027 |
54 | Legionellosis_Homo sapiens_hsa05134 | 1.16960857 |
55 | RNA polymerase_Homo sapiens_hsa03020 | 1.16226367 |
56 | RNA transport_Homo sapiens_hsa03013 | 1.14164404 |
57 | Lysosome_Homo sapiens_hsa04142 | 1.14051061 |
58 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 1.14013514 |
59 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.12576067 |
60 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.12110796 |
61 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.10968055 |
62 | Carbon metabolism_Homo sapiens_hsa01200 | 1.08782319 |
63 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.08694238 |
64 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.07388292 |
65 | Platelet activation_Homo sapiens_hsa04611 | 1.06057374 |
66 | Influenza A_Homo sapiens_hsa05164 | 1.03331600 |
67 | Long-term depression_Homo sapiens_hsa04730 | 1.02922275 |
68 | Phagosome_Homo sapiens_hsa04145 | 1.01645127 |
69 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.01312169 |
70 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.00709573 |
71 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.00627583 |
72 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.98916038 |
73 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.98741774 |
74 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.98628511 |
75 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.96950001 |
76 | Parkinsons disease_Homo sapiens_hsa05012 | 0.95701145 |
77 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.94552056 |
78 | Pertussis_Homo sapiens_hsa05133 | 0.94083664 |
79 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.93226984 |
80 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.92756580 |
81 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.92453811 |
82 | Apoptosis_Homo sapiens_hsa04210 | 0.91752142 |
83 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.90313022 |
84 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.89533379 |
85 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.89188115 |
86 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.87641424 |
87 | Basal transcription factors_Homo sapiens_hsa03022 | 0.86891343 |
88 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.86447380 |
89 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.86026265 |
90 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.85814181 |
91 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.85520033 |
92 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.84600836 |
93 | Other glycan degradation_Homo sapiens_hsa00511 | 0.82114434 |
94 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.81491070 |
95 | Salmonella infection_Homo sapiens_hsa05132 | 0.81488644 |
96 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.81299845 |
97 | Axon guidance_Homo sapiens_hsa04360 | 0.80355227 |
98 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.80089099 |
99 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.78366906 |
100 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.78285068 |
101 | Viral myocarditis_Homo sapiens_hsa05416 | 0.76571598 |
102 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.76206802 |
103 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.75610857 |
104 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.74789701 |
105 | Insulin resistance_Homo sapiens_hsa04931 | 0.73862666 |
106 | Thyroid cancer_Homo sapiens_hsa05216 | 0.69079121 |
107 | Hepatitis C_Homo sapiens_hsa05160 | 0.68837367 |
108 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.68729945 |
109 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.68515860 |
110 | Base excision repair_Homo sapiens_hsa03410 | 0.68193803 |
111 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.66644212 |
112 | Hepatitis B_Homo sapiens_hsa05161 | 0.66545674 |
113 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.66447801 |
114 | Measles_Homo sapiens_hsa05162 | 0.66237539 |
115 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.65785190 |
116 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.65463043 |
117 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.65454861 |
118 | Proteasome_Homo sapiens_hsa03050 | 0.65421837 |
119 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.65272615 |
120 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.65014808 |
121 | Huntingtons disease_Homo sapiens_hsa05016 | 0.65013699 |
122 | Lysine degradation_Homo sapiens_hsa00310 | 0.60966013 |
123 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.60259584 |
124 | * Taste transduction_Homo sapiens_hsa04742 | 0.60256694 |
125 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.59596181 |
126 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.59339767 |
127 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.59312652 |
128 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.59190166 |
129 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.58622572 |
130 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.58583498 |
131 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.57987815 |
132 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.57872722 |
133 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.56904055 |
134 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.55002946 |
135 | Bladder cancer_Homo sapiens_hsa05219 | 0.54607562 |
136 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.53432096 |
137 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.53285985 |
138 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.51086274 |
139 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.48989341 |
140 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.48864674 |
141 | Purine metabolism_Homo sapiens_hsa00230 | 0.48680194 |
142 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.47664947 |
143 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.46325645 |
144 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.44825785 |
145 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.44694515 |
146 | Prion diseases_Homo sapiens_hsa05020 | 0.44655248 |
147 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.44432899 |
148 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.44340392 |
149 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.43592882 |
150 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.42768051 |
151 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.42484494 |
152 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.41738050 |
153 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.41722144 |
154 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.41401088 |
155 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.41219115 |
156 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.41203137 |
157 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.41088864 |
158 | Olfactory transduction_Homo sapiens_hsa04740 | 0.41086787 |
159 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.40745219 |
160 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.40173260 |
161 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.39447855 |
162 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.39434298 |
163 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.38684051 |
164 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.38141382 |
165 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.38001831 |
166 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.37881752 |
167 | Metabolic pathways_Homo sapiens_hsa01100 | 0.37266071 |
168 | Alzheimers disease_Homo sapiens_hsa05010 | 0.36859771 |
169 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.33447095 |
170 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.33085319 |
171 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.32348729 |
172 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.29841028 |
173 | Homologous recombination_Homo sapiens_hsa03440 | 0.29536053 |
174 | Sulfur relay system_Homo sapiens_hsa04122 | 0.27613873 |
175 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.24866809 |
176 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.24007298 |
177 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.20687283 |
178 | Pathways in cancer_Homo sapiens_hsa05200 | 0.18482455 |
179 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.17890264 |
180 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.17618715 |
181 | Shigellosis_Homo sapiens_hsa05131 | 0.17336511 |
182 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.14818828 |
183 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.14349492 |
184 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.13438960 |